TGF-β and the TGF-β family: context-dependent roles in cell and tissue physiology

Morikawa, Masato, Derynck, Rik, Miyazono, Kohei·2016·Cold Spring Harbor Perspectives in Biology
DOI 10.1101/cshperspect.a021873

Cites (231)

Items 201–231 of 231

  1. Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.
    C A Wilson, Nathalie di Clemente, Christian W. Ehrenfels · 1993 · Molecular Endocrinology
  2. Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity
    Olov Andersson, Marion Korach-André, Eva Reissmann, Carlos F. Ibáñez, Philippe Bertolino · 2008 · Proceedings of the National Academy of Sciences
  3. Perturbation of transforming growth factor (TGF)-ß1 association with latent TGF-β binding protein yields inflammation and tumors
    Keiji Yoshinaga, Hiroto Obata, Vladimir Jurukovski, Roberta Mazzieri, Yan Chen, Lior Zilberberg, David L. Huso, Jonathan Melamed, Petra Prijatelj, Vesna Todorović et al. · 2008 · Proceedings of the National Academy of Sciences
  4. Structure of bone morphogenetic protein 9 procomplex
    Li-Zhi Mi, Christopher T. Brown, Yijie Gao, Yuan Tian, Viet Q. Le, Thomas Walz, Timothy A. Springer · 2015 · Proceedings of the National Academy of Sciences
  5. Lefty at the Crossroads of “Stemness” and Differentiative Events
    SIAMAK S. TABIBZADEH, Ali Hemmati‐Brivanlou · 2006 · Stem Cells
  6. In Vivo Studies of Mutant Fibrillin-1 Microfibrils
    Noé L. Charbonneau, Eric J. Carlson, Sara F. Tufa, Gerhard Sengle, Elise C. Manalo, Valerie M. Carlberg, Francesco Ramirez, Douglas R. Keene, Lynn Y. Sakai · 2010 · Journal of Biological Chemistry
  7. Anchorage‐independent growth of primary rat embryo cells is induced by platelet‐derived growth factor and inhibited by type‐beta transforming growth factor
    Mario A. Anzano, Anita B. Roberts, Michael B. Sporn · 1986 · Journal of Cellular Physiology
  8. Transforming Growth Factor β Promotes Neuronal Cell Fate of Mouse Cortical and Hippocampal Progenitors In Vitro and In Vivo: Identification of Nedd9 as an Essential Signaling Component
    Tanja Vogel, Sandra Ahrens, Nicole Büttner, Kerstin G. KRIEGLSTEIN · 2009 · Cerebral Cortex
  9. Transforming Growth Factor-β Can Suppress Tumorigenesis through Effects on the Putative Cancer Stem or Early Progenitor Cell and Committed Progeny in a Breast Cancer Xenograft Model
    Binwu Tang, Naomi Yoo, Mary A. Vu, Mizuko Mamura, Jeong‐Seok Nam, Akira Ooshima, Zhijun Du, Pierre Yves Desprez, Miriam R. Anver, Aleksandra M. Michalowska et al. · 2007 · Cancer Research
  10. Domain-specific Mutations of a Transforming Growth Factor (TGF)-β1 Latency-associated Peptide Cause Camurati-Engelmann Disease Because of the Formation of a Constitutively Active Form of TGF-β1
    Takashi Saito, Akira Kinoshita, Koh-ichiro Yoshiura, Yoshio Makita, Keiko Wakui, Koichi Honke, Norio Niikawa, Naoyuki Taniguchi · 2001 · Journal of Biological Chemistry
  11. Differential effects of epidermal growth factor, transforming growth factor, and insulin on DNA and protein synthesis and morphology in serum-free cultures of AKR-2B cells.
    Gary D. Shipley, C B Childs, Mary E. Volkenant · 1984 · PubMed
  12. Graded Nodal/Activin Signaling Titrates Conversion of Quantitative Phospho-Smad2 Levels into Qualitative Embryonic Stem Cell Fate Decisions
    Kian Leong Lee, Sandy Keat Lim, Yuriy Lvovich Orlov, Le Yau Yit, Henry He Yang, Lay Teng Ang, Lorenz Poellinger, Bing Lim · 2011 · PLoS Genetics
  13. Xenopus GDF6, a new antagonist of noggin and a partner of BMPs
    Chenbei Chang, Ali Hemmati‐Brivanlou · 1999 · Development
  14. BSC-1 growth inhibitor/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation.
    H. Ristow · 1986 · Proceedings of the National Academy of Sciences
  15. Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells
    Shogo Ehata, E. Johansson, Ryohei Katayama, S Koike, Akira Watanabe, Y Hoshino, Yoko Katsuno, Akiyoshi Komuro, Daizo Koinuma, Mitsunobu R. Kano et al. · 2010 · Oncogene
  16. Regulation of miRNA biogenesis as an integrated component of growth factor signaling
    Matthew T. Blahna, Akiko Hata · 2013 · Current Opinion in Cell Biology
  17. An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules
    Huaxia Qin, Michael WY Chan, Sandya Liyanarachchi, Curtis Balch, Dustin Potter, Irene J Souriraj, Alfred S.L. Cheng, Francisco Agosto-Perez, Elena V. Nikonova, Pearlly S. Yan et al. · 2009 · BMC Systems Biology
  18. The paradoxical TGF-β vasculopathies
    Rosemary J. Akhurst · 2012 · Nature Genetics
  19. Selective Inhibition of Growth-Related Gene Expression in Murine Keratinocytes by Transforming Growth Factor β
    Robert J. Coffey, Charles C. Bascom, Nancy J. Sipes, Ramona Graves‐Deal, Bernard E. Weissman, Harold L. Moses · 1988 · Molecular and Cellular Biology
  20. Promoter‐wide analysis of Smad4 binding sites in human epithelial cells
    Daizo Koinuma, Shuichi Tsutsumi, Naoko Kamimura, Takeshi Imamura, Hiroyuki Aburatani, Kohei Miyazono · 2009 · Cancer Science
  21. Smad4 Decreases the Population of Pancreatic Cancer–Initiating Cells through Transcriptional Repression of ALDH1A1
    Yukari Hoshino, Jun Nishida, Yoko Katsuno · 2015 · American Journal Of Pathology
  22. GDF3 is a BMP inhibitor that can activate Nodal signaling only at very high doses
    Ariel J. Levine, Zachary J. Levine, Ali H. Brivanlou · 2008 · Developmental Biology
  23. Neutralization of transforming growth factor-beta 1 in a mouse model of immune-induced lung fibrosis.
    M Denis · 1994 · PubMed Central
  24. Simultaneous Suppression of TGF-β and ERK Signaling Contributes to the Highly Efficient and Reproducible Generation of Mouse Embryonic Stem Cells from Previously Considered Refractory and Non-permissive Strains
    Seyedeh‐Nafiseh Hassani, Mehdi Totonchi, Ali Farrokhi · 2011 · Stem Cell Reviews and Reports
  25. In Xenopus Embryos, BMP Heterodimers Are Not Required for Mesoderm Induction, but BMP Activity Is Necessary for Dorsal/Ventral Patterning
    Peter M. Eimon, Richard M. Harland · 1999 · Developmental Biology
  26. Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy
    Enza Lonardo, Patrick Christian Hermann, Maria-Theresa Mueller, Stephan M. Huber, Anamaria Balic, Irene Miranda‐Lorenzo, Sladjana Zagorac, Sonia Alcalá, Iker Rodríguez-Arabaolaza, Juan Carlos Ramírez et al. · 2012 · Cell stem cell
  27. Context-dependent Action of Transforming Growth Factor β Family Members on Normal and Cancer Stem Cells
    Laia Caja, Kaoru Kahata, Aristidis Moustakas · 2012 · Current Pharmaceutical Design
  28. Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors
    Hiroaki Ikushima, Tomoki Todo, Yasushi Ino · 2009 · Cell stem cell
  29. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies
    Geoffrey C. Gurtner · 2010 · Yearbook of Plastic and Aesthetic Surgery
  30. 11 Growth Control by TGF-β: Mechanisms Controlling Cell Cycle Progression and Apoptosis
    Peter M. Siegel, Joan Massagué · 2008 · Cold Spring Harbor Monograph Archive
  31. SB-431542 and Gleevec inhibit transforming growth factor-β-induced proliferation of human osteosarcoma cells
    茂生 松山 · 2006 · Medical Entomology and Zoology